Literature DB >> 26711857

Evidence of anhedonia and differential reward processing in prefrontal cortex among post-withdrawal patients with prescription opiate dependence.

A S Huhn1, R E Meyer1, J D Harris1, H Ayaz2, E Deneke3, D M Stankoski1, S C Bunce4.   

Abstract

Anhedonia is an important but understudied element of a neuroadaptive model underlying vulnerability to relapse in opioid dependence. Previous research using fMRI has shown reduced activation to pleasant stimuli in rostral prefrontal cortex among heroin-dependent patients in early recovery. This study evaluated the presence of anhedonia among recently withdrawn prescription opiate dependent patients (PODP) in residential treatment compared to control subjects. Anhedonia was assessed using self-report, affect-modulated startle response (AMSR), and a cue reactivity task during which participant's rostral prefrontal cortex (RPFC) and ventrolateral prefrontal cortex (VLPFC) was monitored with functional near infrared spectroscopy (fNIRS). The cue reactivity task included three distinct categories of natural reward stimuli: highly palatable food, positive social situations, and intimate (non-erotic) interactions. PODP reported greater anhedonia on self-report (Snaith-Hamilton Pleasure Scale), and showed reduced hedonic response to positive stimuli in the AMSR task relative to controls. PODP also exhibited reduced neural activation in bilateral RPFC and left VLPFC in response to food images and reduced left VLPFC in response to images depicting positive social situations relative to controls. No differences were found for emotionally intimate stimuli. When patients were divided into groups based on the Snaith-Hamilton criteria for the presence or absence of anhedonia, patients endorsing anhedonia showed reduced neural responses to images depicting positive social stimuli and food relative to patients who did not endorse anhedonia. Activations were in areas of RPFC that support the retrieval of episodic memories. The results suggest the presence of anhedonia in a subsample of PODP.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Affect modulated startle response; Anhedonia; Cue reactivity; Functional near-infrared spectroscopy; Lack of pleasure; Prescription opioids

Mesh:

Year:  2015        PMID: 26711857      PMCID: PMC4893930          DOI: 10.1016/j.brainresbull.2015.12.004

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  60 in total

1.  Persistence of a "subacute withdrawal syndrome" following chronic ethanol intake.

Authors:  H Begleiter; B Porjesz
Journal:  Drug Alcohol Depend       Date:  1979 May-Jul       Impact factor: 4.492

Review 2.  Functional near infrared spectroscopy (fNIRS): an emerging neuroimaging technology with important applications for the study of brain disorders.

Authors:  Farzin Irani; Steven M Platek; Scott Bunce; Anthony C Ruocco; Douglas Chute
Journal:  Clin Neuropsychol       Date:  2007-01       Impact factor: 3.535

3.  Conditioning factors in drug abuse: can they explain compulsion?

Authors:  C P O'Brien; A R Childress; R Ehrman; S J Robbins
Journal:  J Psychopharmacol       Date:  1998       Impact factor: 4.153

4.  Compliance with buprenorphine medication-assisted treatment and relapse to opioid use.

Authors:  Joseph Tkacz; Jamie Severt; John Cacciola; Charles Ruetsch
Journal:  Am J Addict       Date:  2011-11-18

5.  A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale.

Authors:  R P Snaith; M Hamilton; S Morley; A Humayan; D Hargreaves; P Trigwell
Journal:  Br J Psychiatry       Date:  1995-07       Impact factor: 9.319

6.  Beyond cue reactivity: blunted brain responses to pleasant stimuli predict long-term smoking abstinence.

Authors:  Francesco Versace; Cho Y Lam; Jeffrey M Engelmann; Jason D Robinson; Jennifer A Minnix; Victoria L Brown; Paul M Cinciripini
Journal:  Addict Biol       Date:  2011-10-04       Impact factor: 4.280

7.  Postcocaine anhedonia. An animal model of cocaine withdrawal.

Authors:  A Markou; G F Koob
Journal:  Neuropsychopharmacology       Date:  1991-01       Impact factor: 7.853

8.  Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies.

Authors:  Nora D Volkow; Joanna S Fowler; Gene-Jack Wang; Rita Z Goldstein
Journal:  Neurobiol Learn Mem       Date:  2002-11       Impact factor: 2.877

9.  Impaired response inhibition function in abstinent heroin dependents: an fMRI study.

Authors:  Li-ping Fu; Guo-hua Bi; Zhi-tong Zou; Yan Wang; En-mao Ye; Lin Ma; Zheng Yang
Journal:  Neurosci Lett       Date:  2008-04-16       Impact factor: 3.046

Review 10.  Anhedonia and major depression: the role of agomelatine.

Authors:  Massimo Di Giannantonio; Giovanni Martinotti
Journal:  Eur Neuropsychopharmacol       Date:  2012       Impact factor: 4.600

View more
  21 in total

1.  Intact responses to non-drug rewards in long-term opioid maintenance treatment.

Authors:  Marie Eikemo; Philipp P Lobmaier; Mads L Pedersen; Nikolaj Kunøe; Anna Maria Matziorinis; Siri Leknes; Monica Sarfi
Journal:  Neuropsychopharmacology       Date:  2019-03-31       Impact factor: 7.853

Review 2.  μ opioid receptor, social behaviour and autism spectrum disorder: reward matters.

Authors:  Lucie P Pellissier; Jorge Gandía; Thibaut Laboute; Jérôme A J Becker; Julie Le Merrer
Journal:  Br J Pharmacol       Date:  2017-05-04       Impact factor: 8.739

3.  Deficits in autonomic indices of emotion regulation and reward processing associated with prescription opioid use and misuse.

Authors:  Eric L Garland; Craig J Bryan; Yoshio Nakamura; Brett Froeliger; Matthew O Howard
Journal:  Psychopharmacology (Berl)       Date:  2016-12-08       Impact factor: 4.530

4.  Daily sleep quality affects drug craving, partially through indirect associations with positive affect, in patients in treatment for nonmedical use of prescription drugs.

Authors:  David M Lydon-Staley; H Harrington Cleveland; Andrew S Huhn; Michael J Cleveland; Jonathan Harris; Dean Stankoski; Erin Deneke; Roger E Meyer; Scott C Bunce
Journal:  Addict Behav       Date:  2016-08-15       Impact factor: 3.913

5.  Anhedonia as a key clinical feature in the maintenance and treatment of opioid use disorder.

Authors:  Brian D Kiluk; Sarah W Yip; Elise E DeVito; Kathleen M Carroll; Mehmet Sofuoglu
Journal:  Clin Psychol Sci       Date:  2019-09-23

6.  Leveraging crowdsourcing methods to collect qualitative data in addiction science: Narratives of non-medical prescription opioid, heroin, and fentanyl use.

Authors:  Justin C Strickland; Grant A Victor
Journal:  Int J Drug Policy       Date:  2019-11-18

7.  Addiction: A preclinical and clinical analysis.

Authors:  Patricia Sue Grigson
Journal:  Brain Res Bull       Date:  2016-03-19       Impact factor: 4.077

8.  Prefrontal cortex response to drug cues, craving, and current depressive symptoms are associated with treatment outcomes in methadone-maintained patients.

Authors:  Andrew S Huhn; Mary M Sweeney; Robert K Brooner; Michael S Kidorf; D Andrew Tompkins; Hasan Ayaz; Kelly E Dunn
Journal:  Neuropsychopharmacology       Date:  2018-10-30       Impact factor: 7.853

9.  Accounting for the uncounted: Physical and affective distress in individuals dropping out of oral naltrexone treatment for opioid use disorder.

Authors:  Kathleen M Carroll; Charla Nich; Tami L Frankforter; Sarah W Yip; Brian D Kiluk; Elise E DeVito; Mehmet Sofuoglu
Journal:  Drug Alcohol Depend       Date:  2018-10-04       Impact factor: 4.492

10.  The effects of acute stress on consummatory and motivational responses for sucrose in rats after long-term withdrawal from morphine.

Authors:  Yunjing Bai; Yue Zhang; Shaofei Jiang; Xigeng Zheng; Zhengkui Liu
Journal:  Psychopharmacology (Berl)       Date:  2019-07-12       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.